Correction to "1-[5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1h-Pyrrol-3-Yl]-N-Methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases."
Journal of Pharmacology and Experimental Therapeutics - United States